BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4853610)

  • 21. Carbachol-methohexitone interactions at the chick neuromuscular junction: experiments with the moving fluid electrode technique.
    Elliott RC; Wali FA
    Neuropharmacology; 1983 Feb; 22(2):151-5. PubMed ID: 6835484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental acetylcholine blockade of the neuromuscular junction. Effects on end plate and muscle fiber ultrastructure.
    Freeman SS; Engel AG; Drachman DB
    Ann N Y Acad Sci; 1976; 274():46-59. PubMed ID: 1066994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Department of Pharmacology, The School of Pharmacy, University of London, London, Great Britain.
    Brown DA; Fumagalli L
    Brain Res; 1977 Jun; 129(1):165-8. PubMed ID: 194659
    [No Abstract]   [Full Text] [Related]  

  • 24. The distribution of acetylcholine sensitivity over uninnervated and innervated muscle fibers grown in cell culture.
    Fischbach GD; Cohen SA
    Dev Biol; 1973 Mar; 31(1):147-62. PubMed ID: 4787184
    [No Abstract]   [Full Text] [Related]  

  • 25. N,O-di and N,N,O-tri ( 3 H) acetyl -bungarotoxins as specific labelling agents of cholinergic receptors.
    Chang CC; Chen TF; Chuang ST
    Br J Pharmacol; 1973 Jan; 47(1):147-60. PubMed ID: 4717015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pre-junctional site of action of Enhydrina schistosa venom at the neuromuscular junction.
    Geh SL; Chan KE
    Eur J Pharmacol; 1973 Feb; 21(2):115-20. PubMed ID: 4696097
    [No Abstract]   [Full Text] [Related]  

  • 27. Mechanism of action of amantadine on neuromuscular transmission.
    Tsai MC; Mansour NA; Eldefrawi AT; Eldefrawi ME; Albuquerque EX
    Mol Pharmacol; 1978 Sep; 14(5):787-803. PubMed ID: 213703
    [No Abstract]   [Full Text] [Related]  

  • 28. Cholinergic receptor labelling specific irreversible binding of bromoacetylcholine to cholinergic receptors at neuromuscular junctions.
    Chiou CY
    Eur J Pharmacol; 1974 May; 26(2):268-76. PubMed ID: 4546755
    [No Abstract]   [Full Text] [Related]  

  • 29. Agonist-induced myopathy at the neuromuscular junction is mediated by calcium.
    Leonard JP; Salpeter MM
    J Cell Biol; 1979 Sep; 82(3):811-9. PubMed ID: 511934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions between tetraethylammonium and methohexitone at the chick neuromuscular junction. Experiments with the moving fluid electrode technique.
    Elliott RC; Wali FA
    Biochem Pharmacol; 1983 Feb; 32(4):671-7. PubMed ID: 6830630
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on the pharmacology of skeletal muscle in culture: specificity of receptors.
    Harvey AL; Dryden WF
    Eur J Pharmacol; 1974 Sep; 28(1):125-30. PubMed ID: 4154203
    [No Abstract]   [Full Text] [Related]  

  • 32. Proceedings: The effects of some bungarotoxins on skeletal muscle fibres in tissue culture.
    Harvey AL; Dryden WF; Marshall IG
    J Pharm Pharmacol; 1973 Dec; 25():Suppl:126P-127. PubMed ID: 4150524
    [No Abstract]   [Full Text] [Related]  

  • 33. Differences in purity of commercial samples of hemicholinium-3: effects on high affinity choline uptake, neuromuscular transmission, acetylcholinesterase and carbachol and acetylcholine contractions.
    Clement JG; Lockwood PA; Rylett BJ; Colhoun EH
    Life Sci; 1979 Feb; 24(7):615-20. PubMed ID: 220479
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of receptor desensitization on the action of alpha-bungaro-toxin on cultured skeletal muscle.
    Dryden WF; Harvey AL
    Br J Pharmacol; 1974 Jul; 51(3):456-8. PubMed ID: 4476225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The in vitro neuromuscular blocking properties of sea snake (Enhydrina schistosa) venom.
    Walker MJ; Peng-Nam-Yeoh
    Eur J Pharmacol; 1974 Sep; 28(1):199-208. PubMed ID: 4430322
    [No Abstract]   [Full Text] [Related]  

  • 36. Innervation and acetylcholine sensitivity of skeletal muscle cells differentiated in vitro from chick embryo.
    Kano M; Shimada Y
    J Cell Physiol; 1971 Oct; 78(2):233-42. PubMed ID: 4333456
    [No Abstract]   [Full Text] [Related]  

  • 37. Amphetamine inhibition of alpha-bungarotoxin binding at the mouse neuromuscular junction.
    Skau KA; Gerald MC
    Life Sci; 1977 May; 20(9):1495-9. PubMed ID: 195174
    [No Abstract]   [Full Text] [Related]  

  • 38. The neuromuscular effects of quinidine.
    Miller RD; Way WL; Katzung BG
    Proc Soc Exp Biol Med; 1968 Oct; 129(1):215-7. PubMed ID: 5686515
    [No Abstract]   [Full Text] [Related]  

  • 39. Sites of action of phencyclidine. I. Effects on the electrical excitability and chemosensitive properties of the neuromuscular junction of skeletal muscle.
    Tsai MC; Albuquerque EX; Aronstam RS; Eldefrawi AT; Eldefrawi ME; Triggle DJ
    Mol Pharmacol; 1980 Sep; 18(2):159-66. PubMed ID: 6968397
    [No Abstract]   [Full Text] [Related]  

  • 40. Induction of action potentials in frog slow muscle fibres paralysed by alpha -bungarotoxin.
    Miledi R; Uchitel OD
    Proc R Soc Lond B Biol Sci; 1981 Oct; 213(1191):243-8. PubMed ID: 6120517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.